Clinical Trials on Parkinson Disease Dementia in Netherlands

Total 11250 results

Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating How Quickly And To What Extent The 14-Carbon-SAM-531 Is Absorbed/Converted/Eliminated In Male Subjects

Alzheimer Disease

Netherlands
Maastricht University Medical Center
Netherlands Organisation for Scientific Research

Unknown

The Locus Coeruleus and Memory (LOCUS)

Alzheimer's Disease

Netherlands
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Single Ascending Dose Study of SRA-444 in Healthy Subjects

Alzheimer Disease

Netherlands
Radboud University Medical Center

Completed

Empowerment Intervention for Persons With Young Onset Dementia

Dementia | Empowerment

Netherlands
AbbVie

Completed

A Study to Evaluate the Safety and Tolerability of ABBV-951 in Subjects With Parkinson's Disease (PD)

Parkinson's Disease (PD)

United States, Australia, Belgium, Canada, Denmark, Germany, Italy, Japan, Netherlands, Russian Federation, Spain, Sweden, United Kingdom
UCB Biopharma SRL

Active, not recruiting

A 18-month Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Oral UCB0599 in Study Participants With Early-stage Parkinson's Disease (ORCHESTRA)

Early-stage Parkinson's Disease

United States, Canada, France, Germany, Italy, Netherlands, Poland, Spain, United Kingdom
Amsterdam UMC, location VUmc

Suspended

Positron Emission Tomography of Amyloid in Alzheimer's Disease

Alzheimer's Disease

Netherlands
NewAmsterdam Pharma

Completed

Proof-of-concept, Open-label Study in Patients With Early Alzheimer's Disease

Early Alzheimer's Disease

Netherlands
Radboud University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Completed

Systematic Care for Informal Caregivers of Dementia Patients: An Efficient Approach?

Dementia | Alzheimer Disease | Lewy Body Disease | Dementia, Vascular

Netherlands
AbbVie (prior sponsor, Abbott)
Quintiles, Inc.

Completed

Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's Disease

Advanced Parkinson's Disease

United States, Australia, Canada, Czech Republic, Finland, Germany, Israel, Italy, Netherlands, New Zealand, Poland, Portugal, Russian Federation, Spain, Thailand, United Kingdom
Maastricht University Medical Center

Completed

Acceptance and Commitment Therapy for Informal Caregivers of People With Dementia (ACT-IC)

No Specific Conditions

Netherlands
Maastricht University Medical Center

Completed

Blood-brain Barrier Permeability in Alzheimer's Disease

Alzheimer's Disease

Netherlands
Radboud University Medical Center
Michael J. Fox Foundation for Parkinson's Research; ZonMw: The Netherlands...

Completed

Effectiveness of an Active Lifestyle Promotion Program for Patients With Parkinson's Disease (ParkFit)

Parkinson's Disease

Netherlands
Alkermes, Inc.
University Medical Center Groningen; Amsterdam UMC, location VUmc; QPS Netherlands...

Completed

A Non-therapeutic Feasibility Study of the Radioligand [11C]-UCB-J for Imaging Synaptic Density

Healthy | Alzheimer Disease

Netherlands
Radboud University Medical Center
Netherlands Brain Foundation; Netherlands Alzheimer Foundation; American Health...

Completed

Effect of Indomethacin on the Progression of Alzheimer's Disease

Alzheimer Disease

Netherlands
Maastricht University Medical Center
Funding: Stichting Internationaal Parkinson Fonds, The Netherlands

Completed

Transcranial Duplex Scanning and Single Photon Emission Computer Tomography (SPECT) in Parkinsonian Syndromes

Parkinson's Disease | Supranuclear Palsy, Progressive | Multiple System Atrophy | Essential Tremor | Vascular Parkinsonism | Parkinsonian Syndrome | Drug Induced Parkinsonism

Netherlands
Boehringer Ingelheim

Completed

A Randomized, Double-blind, Placebo-controlled, Five Parallel Groups Efficacy and Safety Study of NS 2330 (Tesofensine) (0.125 mg, 0.25 mg, 0.5 mg and 1.0 mg) Administered Orally Once Daily Over 14 Weeks in Levodopa Treated Parkinson Patients With Motor Fluctuations

Parkinson Disease

Spain, Germany, France, Austria, United Kingdom, Netherlands
Radboud University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Recruiting

Video Feedback Intervention in Nursing Home Residents With Dementia and Severe Challenging Behavior.

Dementia | Challenging Behavior | Nursing Home Resident

Netherlands
Bayer

Completed

Evaluation of the Neuroinflammation Pattern of BAY85-8102 F-18, DPA-714 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of F 18, DPA-714 in Healthy Volunteers

Diagnostic Imaging

Finland, Netherlands
reMYND

Terminated

A Phase 2a Study to Investigate REM0046127 in Mild to Moderate Alzheimer's Disease

Alzheimer Disease

Netherlands, Spain
Novartis

Completed

A Study of Three Doses of TCH346 in Patients With Early Parkinson's Disease to Evaluate Safety and Efficacy

Parkinson's Disease

United States, France, Germany, Portugal, Netherlands, United Kingdom, Italy, Canada, Brazil
Bayer

Completed

Evaluation of ZK 6032924 in Probable Alzheimer's Disease Patients Versus Healthy Volunteers and the Radiation Dosimetry of ZK 6032924 in Healthy Volunteers

Alzheimer's Disease | Positron-Emission Tomography

Netherlands, Sweden
Saxion University of Applied Sciences
Radboud University Medical Center; Amsterdam UMC, location VUmc; University of...

Completed

Pilot Study Person-centred Tablet Intervention

Neurological Rehabilitation | Dementia | Mobile Applications | Activities of Daily Living | Computers

Netherlands
University Medical Center Groningen
ZonMw: The Netherlands Organisation for Health Research and Development; Health∼Holland...

Completed

Prevalence and Recognition of Cognitive Impairment in Hospitalized Patients: a Flash Mob Study

Delirium | Cognitive Impairment | Dementia | Alzheimer Disease

Netherlands
Boehringer Ingelheim

Completed

Profile of Depressive Symptoms in Parkinsons Disease

Depression | Parkinson Disease

Netherlands, Germany, Italy, Switzerland, Austria, France, Spain, United Kingdom
Acorda Therapeutics

Completed

Randomized Safety Study of CVT-301 Compared to an Observational Control Group

Idiopathic Parkinson's Disease

United States, Austria, Belgium, Czechia, France, Germany, Hungary, Israel, Netherlands, Poland, Romania, Serbia, Spain, United Kingdom
Maastricht University Medical Center
Radboud University Medical Center; Amsterdam UMC, location VUmc; Leiden University... and other collaborators

Completed

Health Technology Assessment of Diagnostic Approaches in Alzheimer's Disease

Neurodegenerative Diseases | Memory Disturbances

Netherlands
AviadoBio Ltd

Recruiting

A Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Frontotemporal Dementia (FTD-GRN) (ASPIRE-FTD)

Frontotemporal Dementia | FTD | FTD-GRN | Dementia, Frontotemporal

Netherlands, Spain, Poland, United States
Amsterdam UMC, location VUmc

Not yet recruiting

Memory Enhancement Using Transcranial Alternating Current Stimulation (Memento)

Alzheimer Disease | Mild Cognitive Impairment

Netherlands
Maastricht University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Completed

The Effects and Cost-Effectiveness of an Integrated Multidisciplinary Approach for Psychogeriatric Patients

Memory Disorders | Delirium, Dementia, Amnestic, Cognitive Disorders

Netherlands
Maastricht University Medical Center

Recruiting

The TearAD Study: Tear Biomarkers for Alzheimer's Disease (AD) Screening and Diagnosis (TearAD)

Alzheimer Disease

Netherlands
Radboud University Medical Center
European Union

Completed

Delta-THC in Behavioral Disturbances in Dementia

Dementia

Netherlands
EIP Pharma Inc

Completed

A PET Study of the Effects of p38 MAP Kinase Inhibitor, VX-745, on Amyloid Plaque Load in Alzheimer's Disease (AD)

Mild Cognitive Impairment | Alzheimer's Disease

Netherlands
Radboud University Medical Center
Karolinska Institutet; Maastricht University Medical Center; Amsterdam UMC, location... and other collaborators

Completed

Comparison of Effectiveness and Costs of Post-diagnosis Treatment in Dementia (AD-Euro)

Dementia

Netherlands
Bial R&D Investments, S.A.

Recruiting

Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD (ACTIVATE)

Parkinson's Disease

United States, Spain, France, Italy, Netherlands, United Kingdom, Germany, Canada, Poland, Portugal, Sweden
University Medical Center Nijmegen

Completed

Effects of Sleep Deprivation on Cerebrospinal Fluid (CSF) Amyloid-beta (Aβ) Dynamics (AWAKE)

Alzheimer Disease

Netherlands
UCB Biopharma SRL

Enrolling by invitation

An Extension Study to Evaluate the Long-Term Efficacy, Safety and Tolerability of Minzasolmin (UCB0599) in Study Participants With Parkinson's Disease

Parkinson's Disease

United States, Poland, Netherlands, France, Germany, Canada, Italy, Spain, United Kingdom
Janssen Research & Development, LLC

Completed

A Study to Measure CSF Proteins in Elderly Healthy Volunteers and Volunteers With Mild Cognitive Impairment or Alzheimer's Disease

Healthy | Alzheimer Disease

Netherlands, Belgium
Utrecht University
De Waag

Recruiting

The Effectiveness of Forensic Outpatient Systemic Therapy: a Multiple Case Experimental Design (FAST)

Aggression | Conduct Disorder | Behavioral Disorder | Antisocial Behavior

Netherlands
Wave Life Sciences Ltd.

Terminated

Open-label Extension (OLE) Study of WVE-004 in Patients With C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) and/or Frontotemporal Dementia (FTD)

ALS | FTD

Netherlands, United Kingdom
NeuroDerm Ltd.

Active, not recruiting

Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations (BouNDless)

Parkinson's Disease

United States, Israel, Spain, France, Russian Federation, Austria, Italy, Belgium, Czechia, Hungary, Netherlands, Poland, Portugal, Slovakia, Ukraine, United Kingdom
Boehringer Ingelheim

Completed

Long-term Safety Study of Open-label Pramipexole Extended Release (ER) in Patients With Early Parkinson´s Disease (PD).

Parkinson Disease

United States, Austria, Czech Republic, Finland, France, Germany, Hungary, India, Japan, Malaysia, Netherlands, Russian Federation, Slovakia, Taiwan, Ukraine
Treeway B.V.

Recruiting

ASURE: Alzheimer Study Using oRal Edaravone

Alzheimer Disease

Croatia, Netherlands
Teva Branded Pharmaceutical Products R&D, Inc.
H. Lundbeck A/S; Teva Neuroscience, Inc.

Completed

ADAGIO Follow Up Study: Evaluation of the Long-Term Effects of Rasagiline in Parkinson's Disease Subjects

Parkinson's Disease

United States, Argentina, Canada, France, Germany, Hungary, Israel, Italy, Netherlands, Portugal, Romania, Spain, United Kingdom
Michael J. Fox Foundation for Parkinson's Research
Institute for Neurodegenerative Disorders

Recruiting

PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort (PPMI)

Parkinson Disease

United States, Canada, Spain, Israel, Austria, Germany, Greece, Italy, Netherlands, Nigeria, United Kingdom, Luxembourg
Biogen
Denali Therapeutics Inc.

Recruiting

A Study to Assess the Safety of BIIB122 Tablets and if it Can Slow the Worsening of Early-Stage Parkinson's Disease in Participants Between the Ages of 30 and 80 (LUMA)

Parkinson Disease

United States, Netherlands, Italy, Spain, Israel, Canada, China, Germany, France, Austria, United Kingdom, Poland, Japan
Newron Pharmaceuticals SPA

Completed

Safinamide in Idiopathic Parkinson's Disease (IPD) With Motor Fluctuations, as add-on to Levodopa (SETTLE)

Idiopathic Parkinson's Disease

Korea, Republic of, Israel, Thailand, New Zealand, Spain, Canada, United States, Switzerland, Netherlands, Taiwan, United Kingdom, Belgium, Estonia, Germany, Hungary, India, Australia, Austria, France, Malaysia, Slovakia
Radboud University Medical Center

Completed

The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly (BLUEBERRY)

Hypertension | Frailty | Orthostatic Hypotension | Orthostatic Intolerance | Cerebral Hypoperfusion | Old Age; Dementia

Netherlands
GlaxoSmithKline

Completed

A Repeat Dose Study in Healthy Volunteers Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK356278

Huntington Disease

Netherlands
Janssen Research & Development, LLC

Completed

A Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-63733657 in Healthy Subjects and Subjects With Alzheimer's Disease

Alzheimer Disease

Belgium, Spain, Netherlands, Germany

Clinical Trials on Parkinson Disease Dementia in Netherlands

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cyprus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations